StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Biogen (BIIB) PT Raised to $328 at BMO Capital; '2Q17 Couldn’t Have Been Better Operationally'
July 26, 2017 10:53 AM
BMO Capital raised its price target on Biogen (NASDAQ: BIIB) to $328.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst EPS Change
Analyst EPS View
Analyst PT Change
Next Articles
Biogen (BIIB) PT Raised to $285 at UBS Following Strong 2Q
July 26, 2017 8:44 AM
Biogen (BIIB) PT Raised to $311 at Morgan Stanley
July 26, 2017 7:58 AM
Biogen (BIIB) PT Raised to $319 at Deutsche Bank
July 26, 2017 6:24 AM
Goldman Sachs Upgrades Biogen (BIIB) to Buy
July 26, 2017 5:07 AM
Biogen (BIIB) Said Contacted by Prosecution Office of Milan
July 25, 2017 5:13 PM
Biogen (BIIB) CEO says 'we will explore deals of all sizes' - Bloomberg
July 25, 2017 8:54 AM
Ionis (IONS) Partner Biogen Reports Blow-Out Spinraza Sales - BMO Capital
July 25, 2017 7:50 AM
Biogen (BIIB) Tops Q2 EPS by 59c, Sales Beat; Raises Outlook
July 25, 2017 6:31 AM
